Outcomes Explored for ER Return Visit Hospital Admissions

This article originally appeared here.
Share this content:
Outcomes Explored for ER Return Visit Hospital Admissions
Outcomes Explored for ER Return Visit Hospital Admissions

WEDNESDAY, Feb. 17, 2016 (HealthDay News) -- Patients with emergency department visits who are initially discharged and are then admitted at a return visit have better clinical outcomes that those hospitalized at the index emergency department visit without a return visit, according to a study published in the Feb. 16 issue of the Journal of the American Medical Association.

Amber K. Sabbatini, M.D., M.P.H., from the University of Washington in Seattle, and colleagues examined in-hospital clinical outcomes and resource use among patients hospitalized during an unscheduled return visit to the emergency department. The authors identified and followed patients with index emergency department visits for return visits within seven, 14, and 30 days.

The researchers found that patients discharged from the emergency department and admitted to the hospital after a return visit within seven days had significantly lower rates of in-hospital mortality, intensive care unit (ICU) admission, lower mean costs, and longer length of stay than patients who were admitted during the index emergency department visit without a return visit. Compared with patients admitted to the hospital during the index emergency department visit without a return visit, those who returned to the emergency department after discharge and were readmitted had higher rates of in-hospital mortality and ICU admission, longer lengths of stay, and higher costs.

"Hospital admissions associated with return visits to the emergency department may not adequately capture deficits in the quality of care delivered during an emergency department visit," the authors write.

One author disclosed financial ties to Blue Cross Blue Shield of Michigan/Blue Cross Network.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »